Latest Operating Costs News

Epsilon Healthcare has posted a record $2.891 million in receipts for the December 2025 quarter, nearly doubling year-on-year revenue and marking a significant turnaround with its recent ASX reinstatement.

Meteoric Resources has cleared a major regulatory hurdle with the approval of its Preliminary Environmental License for the Caldeira Rare Earths Project, enabling the company to progress towards construction and first production targeted for 2028. The company also commissioned its pilot plant, producing its first batches of rare earth carbonate.

Volt Resources has made significant strides in its US graphite refinery project and secured major funding for its Bunyu Graphite Mine in Tanzania, positioning itself strongly in the critical minerals sector.

X2M Connect Limited reported a robust second quarter for FY26, with revenues climbing 65% and a notable narrowing of EBITDA losses, driven by strategic expansions in South Korea, Japan, and beyond.

Axel REE Limited reports a remarkable 145% increase in rare earth elements and 339% gallium resource growth at its Caladão Project, alongside a metallurgical breakthrough that could slash development costs through in-situ leaching.

Boss Energy delivered a record uranium production quarter at its Honeymoon project, lowering cost guidance and initiating a new feasibility study to reshape its mining strategy.

Rapid Critical Metals has launched a comprehensive scoping study for its NSW silver projects, backed by promising drilling results and advanced ore-sorting technology.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Beforepay Group reported a 17% rise in advances and an 18% increase in revenue for Q2 FY26, while profit fell sharply due to holiday-season defaults and strategic investments.

Finder Energy is accelerating its KTJ oil project in Timor-Leste, securing a key FPSO vessel and a major funding partnership to target first oil by the end of 2027. Strategic alliances and resource upgrades underpin a fast-moving development plan.

Firebrick Pharma has commenced commercial manufacturing and export of its new Nasodine Throat Spray, marking a significant step in its international expansion. The company also reported a 15% increase in cash sales and reduced operating costs, signalling improving financial health.

Grange Resources delivered a robust quarter with increased concentrate output and reduced unit costs at Savage River, while advancing financing for its North Pit Underground project.